Efficacy of natalizumab in second line therapy of relapsing–remitting multiple sclerosis: results from a multi‐center study in German speaking countries
暂无分享,去创建一个
N. Putzki | M. Maschke | V. Limmroth | B. Tettenborn | S. Cursiefen | M. Mäurer | C. Klawe | O. Yaldizli | S. Kuckert